Teva’s Reformulated Levothyroxine Gets Approval from UK’s Commission on Human Medicines
UK drug advisory body Commission on Human Medicines (CHM) has permitted Teva to reintroduce levothyroxine tablets in the United Kingdom
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine